![]() |
![]() Endoluminal bypass for treating Peripheral Vascular Disease (PVD) in the SFA ![]()
|
![]() |
![]() |
Interventionalists treating patients suffering from Peripheral Vascular Disease(PVD)in the Superficial Femoral Artery (SFA) require a flexible stent-graft capable of re-lining tortuous arteries.
The GORE VIABAHN® Endoprosthesis is constructed with a durable, reinforced, biocompatible, expanded polytetrafluoroethylene (ePTFE) liner attached to an external nitinol stent structure. The extreme flexibility of the GORE VIABAHN® Endoprosthesis enables it to better traverse tortuous areas of the SFA and conform more closely to the complex anatomy of the artery. W. L. Gore & Associates has now added a heparin-bonded surface to the GORE VIABAHN® Endoprosthesis.
The GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface is the only device of its kind approved for the SFA. The latest interventional product offering from W. L. Gore & Associates, the stent-graft features the addition of proprietary heparin-bonded technology to the proven combination of ePTFE and Nitinol. End-point covalent bonding keeps heparin anchored to the endoprosthesis surface.
With a new lower-profile, streamlined delivery system, the GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface makes it easier to reach and treat challenging SFA lesions.